Vogenx Inc

Last updated September 27, 2026

Organization details

Legal name
Vogenx Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Raleigh
Headquarters state / province
North Carolina
Headquarters country
United States
Fiscal year end
December
Ticker symbol
VOGX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001903784
EIN
86-3697324

Board of directors

Chief executives

James Green · Chief Executive Officer
Since August 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 13, 2026 Steven R. Delmar Director, Officer (Chief Financial Officer) Derivative conversion +4,273 $11.70 $49,994
Aug 13, 2026 Peter Pieraccini Director Derivative conversion +42,735 $11.70 $500,000

Organizations in the same sector, closest in location and size first.

Questions about Vogenx Inc

Who is the CEO of Vogenx Inc?

James Green has been Vogenx Inc's Chief Executive Officer since August 2026.

How many directors are on Vogenx Inc's board?

Vogenx Inc's board has 7 directors: James Green, Kenneth John Toombs, Peter Pieraccini, Richard M. Gorman, Steven R. Delmar, Timothy Boris and William Wilkison.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="vogenx-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.